News

Lieva has been awarded TÜBİTAK 1501 funding for the project titled “Development of Domestic and Modular Devices for the Diagnosis of Hematological Diseases and an LLM-Supported Clinical Decision Support System.”

We are pleased to announce the first sale of the automated staining device to Samsun City Hospital in Türkiye.

We signed a strategic partnership, mentorship and consultancy agreement with Siemens Healthineers.

We won 15K Euro support in the EIT Health – Innostars competition and qualified to participate in the Grand Final.

We realized our Seed stage investment round with our esteemed investor Süleyman Sadık Özkara. He invested 3.8 Million₺ in our company with a valuation of 47.5 Million₺.

We became one of the 7 startups accepted to the GM2 Young MUSIAD Initiative Center.

Within the scope of 1507-TUBITAK Program 2023/2 Call, our “Blood Staining Device” project was entitled to be supported with an upper limit of 2.4 Million TL.

We completed our Pre-Seed stage investment round with 4.8Million₺ with a valuation of 40Million₺ and 120% funding through the crowdfunding platform Fonbulucu.

We ranked 1st in the Future of Laboratories2 program initiated by Siemens and Acıbadem and were selected as the most successful startup.